| Emthibodeau, Licsw, Llc | |
|
330 New Durham Rd Alton NH 03809-4923 | |
| (603) 941-4878 | |
| (603) 941-0410 |
| Full Name | Emthibodeau, Licsw, Llc |
|---|---|
| Speciality | Social Worker - Clinical |
| Location | 330 New Durham Rd, Alton, New Hampshire |
| Authorized Official Name and Position | Estelle M Thibodeau (OWNER) |
| Authorized Official Contact | 6039414878 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Emthibodeau, Licsw, Llc 330 New Durham Rd Alton NH 03809-4923 Ph: (603) 941-4878 | Emthibodeau, Licsw, Llc 330 New Durham Rd Alton NH 03809-4923 Ph: (603) 941-4878 |
| NPI Number | 1265757470 |
|---|---|
| Provider Enumeration Date | 03/30/2010 |
| Last Update Date | 01/26/2024 |
| Certification Date | 01/26/2024 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265757470 | NPI | - | NPPES |
| 30424430 | Medicaid | NH | |
| 1750304218 | Other | NH | NPI INDIVIDUAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 1328 (New Hampshire) | Primary |
News Archive
Approximately five percent of prescriptions submitted by CVS Caremark Pharmacy Benefit Management (PBM) members in a 30-day period during 2009 included a "dispense as written" (DAW) designation.
Bravo Health today announced that the first Bravo Health Advanced Care Center (the Center) will open in Philadelphia in January 2010. The Center, an innovative, state-of-the-art outpatient physician practice designed to meet the health care needs of Bravo Health members, will be located in a new building being constructed at 1010 W. Lehigh Avenue in North Philadelphia.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced positive results from preclinical toxicology and pharmacokinetic studies of an intravenous (IV) formulation of its novel antibiotic, Restanza™ that support its use in a hospital setting.
With the realization that half of the people experiencing a sudden mortal heart attack were taking aspirin on the day of their demise, and the fact that higher-than-recommended doses of aspirin are needed to prevent blood clot formation in coronary arteries, coupled with an announcement that the red wine molecule resveratrol (rez-vair-ah-trawl) may protect from sudden mortal heart attack in a superior fashion to aspirin, suggests re-evaluation of cardiology's current instruction regarding prevention of heart attacks, says Nate Lebowitz MD, cardiologist with the Advanced Cardiology Institute in Ft. Lee, New Jersey.
› Verified 9 days ago